☆ 4.7 Article

Tricin promoted ATG-7 dependent autophagic degradation of α-synuclein and dopamine release for improving cognitive and motor deficits in Parkinson's disease

PHARMACOLOGICAL RESEARCH (2023)

Related references

Note: Only part of the references are listed.

Article Chemistry, Multidisciplinary

Ursolic acid enhances autophagic clearance and ameliorates motor and non-motor symptoms in Parkinson's disease mice model

Yeojin Bang et al.

Summary: The natural compound ursolic acid (UA) has shown protective effects in experimental models of brain dysfunction and could be a promising therapeutic candidate for reducing Parkinson's disease (PD) progression. It promotes autophagic clearance of protein aggregates, inhibits oxidative stress and inflammatory responses, and suppresses apoptotic signaling. In addition, UA prevents protein accumulation in cells and regulates autophagy by increasing JNK phosphorylation and dissociation of Bcl-2 from Beclin 1.

ACTA PHARMACOLOGICA SINICA (2023)

Add to Collection

Article Neurosciences

Paeoniflorin protects 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mice by inhibiting oxidative stress and neuronal apoptosis through activating the Nrf2/HO-1 signaling pathway

Jingyan Zhang et al.

Summary: The neuroprotective effects of paeoniflorin on oxidative stress and apoptosis were investigated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease (PD) mice. Paeoniflorin significantly improved motor function, increased the expression of dopaminergic neuron markers, reduced neuronal damage and apoptosis, and inhibited oxidative stress through the Nrf2/HO-1 signaling pathway.

NEUROREPORT (2023)

Add to Collection

Review Pharmacology & Pharmacy

Current Treatments and New, Tentative Therapies for Parkinson's Disease

Teresa Pardo-Moreno et al.

Summary: Parkinson's disease is a neurodegenerative pathology caused by the death of dopamine-producing neuronal cells. There are ongoing investigations into novel treatments and therapeutic targets for PD. The pathophysiology involves the formation of alpha-synuclein folds and Lewy bodies, which reduce dopamine levels. Current pharmacological treatments aim to reduce the accumulation of alpha-synuclein. The disease remains of unknown origin and has a significant social impact, but there are various treatments available and under investigation for symptom reduction and improving quality of life. A combination of pharmacological and non-pharmacological strategies is necessary for optimal outcomes.

PHARMACEUTICS (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Neuroinflammation in Parkinson's Disease: From Gene to Clinic: A Systematic Review

Carlos Castillo-Rangel et al.

Summary: Parkinson's disease is closely associated with neuroinflammation, which has a bidirectional and multilevel relationship with the progression and clinical manifestation of the disease. This study conducted a systematic search using various search engines to explore the genetic, cellular, histopathological, and clinical-behavioral alterations related to neuroinflammation in Parkinson's disease. A total of 84 articles were included after screening 585,772 articles, providing valuable information on the multilevel association of neuroinflammation with genetic, molecular, cellular, tissue, and neuroanatomical changes, as well as clinical-behavioral manifestations, in Parkinson's disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Clinical Neurology

Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy The PD MED Randomized Clinical Trial

Richard Gray et al.

Summary: This study compared the long-term effects of adding a dopamine agonist with adding a dopamine reuptake inhibitor (MAO-B or COMT inhibitor) on patient-rated quality of life in PD patients. Results showed that patients using MAO-B inhibitors had better quality of life compared with those using COMT inhibitors.

JAMA NEUROLOGY (2022)

Add to Collection

Article Cell Biology

Piperine promotes autophagy flux by P2RX4 activation in SNCA/alpha-synuclein-induced Parkinson disease model

Ruolin Li et al.

Summary: This study demonstrates that piperine exerts neuroprotective effects in Parkinson's disease models by promoting autophagy flux and degradation of pathological SNCA, suggesting it may be an effective agent for PD treatment.

AUTOPHAGY (2022)

Add to Collection

Article Chemistry, Medicinal

Trehalose ameliorates prodromal non-motor deficits and aberrant protein accumulation in a rotenone-induced mouse model of Parkinson's disease

Soung Hee Moon et al.

Summary: The study revealed that trehalose could modify Parkinson's disease progression by improving non-motor symptoms in the prodromal stage and preventing abnormal protein accumulation in the brain.

ARCHIVES OF PHARMACAL RESEARCH (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Initiation and progression of α-synuclein pathology in Parkinson's disease

George K. Tofaris

Summary: alpha-Synuclein aggregation is a critical molecular process in Parkinson's disease pathogenesis, and its nature influences the clinical heterogeneity. Alpha-synuclein assemblies need to exhibit seeding competency and toxicity for neurodegeneration to occur. It is currently unknown which alpha-synuclein assemblies are most relevant to the human condition.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

A Novel NOX Inhibitor Treatment Attenuates Parkinson's Disease-Related Pathology in Mouse Models

Anurupa A. Ghosh et al.

Summary: This study evaluated the efficacy of a novel NOX inhibitor in Parkinson's disease (PD) models, and found that the compound improved cell viability, reduced ROS levels, and decreased protein aggregation. Both mouse models treated with the compound showed alleviated motor deficits and reduced protein aggregation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease

Ramesh Pariyar et al.

Summary: The anti-diabetic drug vildagliptin has been found to have protective effects against motor dysfunction caused by Parkinson's disease (PD), potentially through the regulation of PI3k/Akt, ERK, and JNK signaling pathways.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase

Toshiharu Nagatsu et al.

Summary: Parkinson's disease is an aging-related neurodegenerative disease characterized by movement disorders and deficiency of dopamine. Lewy bodies and abnormal accumulation of neuromelanin are the histopathological hallmarks of Parkinson's disease, leading to cell death of dopamine neurons.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

The role of autophagy in death of cardiomyocytes

Shohei Ikeda et al.

Summary: Autophagy is a cellular process that helps maintain cellular quality control and energy homeostasis by degrading cellular materials through the lysosomes. It can either adaptively help cells survive stressful conditions or mediate cell death during development and stress response. Dysregulation of autophagy can lead to accumulation of autophagosomes, causing cellular dysfunction and death. In the heart, dysregulated autophagy is associated with cardiomyocyte death and cardiac injury.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2022)

Add to Collection

Review Clinical Neurology

From the tyrosine hydroxylase hypothesis of Parkinson's disease to modern strategies: a short historical overview

Wolf-Dieter Rausch et al.

Summary: Over the span of 60 years, studies have shown the reduced formation of catecholamines and the cell death of dopaminergic neurons as the actual pathological processes in Parkinson's disease. Tyrosine hydroxylase, although initially suspected to be deficient, remains a valuable tool in studying neuronal pathways and neuroprotective strategies.

JOURNAL OF NEURAL TRANSMISSION (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Mitochondrial Sirtuins in Parkinson's Disease

Ling He et al.

Summary: Parkinson's disease (PD) is a common neurodegenerative disease that mainly affects the elderly population and has a significant impact on individuals and the economy. The pathogenesis of PD is still not fully understood, but there is evidence suggesting the involvement of mitochondrial dysfunction, protein aggregation, oxidative stress, inflammation, and autophagy. Mitochondrial sirtuins, especially SIRT3, SIRT4, and SIRT5, play a crucial role in PD by regulating mitochondrial respiratory chain, oxidative stress, inflammatory response, and autophagy. This paper provides a comprehensive summary of studies on the role of mitochondrial sirtuins in PD, offering new insights into the pathogenesis of PD and potential targets for its diagnosis and treatment.

NEUROCHEMICAL RESEARCH (2022)

Add to Collection

Article Multidisciplinary Sciences

Kurarinone alleviated Parkinson's disease via stabilization of epoxyeicosatrienoic acids in animal model

Cheng-Peng Sun et al.

Summary: Kurarinone, a natural compound found in Sophora flavescens, has shown potential as a treatment for Parkinson's disease by attenuating neuroinflammation and protecting dopaminergic neurons.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Add to Collection

Article Chemistry, Medicinal

Licochalcone B, a Natural Autophagic Agent for Alleviating Oxidative Stress-Induced Cell Death in Neuronal Cells and Caenorhabditis elegans Models

Liqun Qu et al.

Summary: The study found that Licochalcone B (LCB) has neuroprotective effects against oxidative stress-induced damage in neuronal cells. It reduces cell cytotoxicity and apoptosis, lowers the level of oxidative stress markers, and induces autophagy and signaling pathways to protect against damage.

PHARMACEUTICALS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis

Zhi Dong Zhou et al.

Summary: This study found that the TH-DA pathway plays a critical role in the pathogenesis of Parkinson's disease. LRRK2 and PINK1 have opposing effects on the TH-DA pathway, and the balance between them affects the survival of DA neurons. Mutations in LRRK2 or PINK1 can disrupt this balance, leading to the demise of DA neurons.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Add to Collection

Review Medicine, Research & Experimental

Emerging roles of ATG7 in human health and disease

Jack J. Collier et al.

Summary: ATG proteins are essential for macroautophagy and play important roles beyond autophagic elimination. Dysfunction of ATG7 is associated with diseases, but the mechanisms of how it contributes to these diseases remain unclear. Further research on the relationship between ATG7 dysfunction and diseases will help develop therapies for disorders involving ATG7 deficiency and impaired autophagy.

EMBO MOLECULAR MEDICINE (2021)

Add to Collection

Article Neurosciences

β-Caryophyllene exerts protective antioxidant effects through the activation of NQO1 in the MPTP model of Parkinson's disease

M. E. Flores-Soto et al.

Summary: The study found that BCP can inhibit oxidative stress-induced cell death of dopaminergic neurons exposed to MPTP while enhancing the expression and enzymatic activity of NQO1. BCP treatment not only improved motor dysfunction but also protected dopaminergic cells of the substantia nigra pars compacta from damage induced by MPTP.

NEUROSCIENCE LETTERS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Neuroprotective Activities of Curcumin in Parkinson's Disease: A Review of the Literature

Eslam El Nebrisi

Summary: Parkinson's disease is a slowly progressive disorder affecting dopaminergic neurons, and the treatment with levodopa often leads to unwanted dyskinesia. The discovery of new therapeutic approaches to slow down or reverse neurodegeneration in PD is a crucial unmet need. Curcumin as a potential therapeutic agent for PD has neuroprotective activities, while alpha 7-nAChR is proposed as a potential therapeutic approach in PD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Clinical Neurology

Amantadine in the treatment of Parkinson's disease and other movement disorders

Olivier Rascol et al.

Summary: Amantadine, discovered serendipitously over 50 years ago, remains a commonly used drug by neurologists for the symptomatic treatment of Parkinson's disease with unique pharmacological actions on dopaminergic and glutamatergic pathways. Recent randomized controlled trials have supported its efficacy in treating levodopa-induced dyskinesias, but evidence for its use in other conditions is lacking. Future research should explore its role in managing motor and non-motor symptoms in patients with Parkinson's disease and other movement disorders.

LANCET NEUROLOGY (2021)

Add to Collection

Article Neurosciences

PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats

Majken B. Thomsen et al.

Summary: The study demonstrates that intrastriatal injection of a-syn fibrils induces progressive synaptic dysfunction and degeneration of dopamine terminals prior to cell death. PET imaging shows a gradual decrease in VMAT2 and SV2A binding in the ipsilateral striatum, while misfolded a-syn pathology spreads anatomically connected regions and becomes bilateral over time. The presence of MHCII positive ramified microglia indicates neuroinflammation in the injected striatum and substantia nigra.

NEUROBIOLOGY OF DISEASE (2021)

Add to Collection

Review Pharmacology & Pharmacy

Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease

Kai Zhang et al.

Summary: Parkinson's disease is a common neurodegenerative disease that can be accelerated by impaired autophagy, which may lead to neuron death. Targeting autophagy with small-molecule compounds is considered a promising strategy in PD treatment.

ACTA PHARMACEUTICA SINICA B (2021)

Add to Collection

Article Microbiology

Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis

Zhe Zhao et al.

Summary: This study demonstrates that FMT treatment can correct gut microbiota dysbiosis and ameliorate the rotenone-induced PD mouse model, possibly playing a significant role in suppressing inflammation via the LPS-TLR4 signaling pathway in both the gut and the brain. Furthermore, the study proves the involvement of rotenone-induced microbiota dysbiosis in the genesis of PD through the microbiota-gut-brain axis.

MICROBIOME (2021)

Add to Collection

Review Medicine, General & Internal

Parkinson's disease

Bastiaan R. Bloem et al.

Summary: Parkinson's disease is a neurodegenerative condition with diverse causes and clinical presentations. Diagnosis is clinically based, and treatment goals vary from person to person, emphasizing the need for personalized management. Currently, there is no therapy to slow down or arrest the progression of Parkinson's disease.

LANCET (2021)

Add to Collection

Review Neurosciences

Novel Pharmacotherapies in Parkinson's Disease

Yousef Tizabi et al.

Summary: Parkinson's disease is an age-related progressive neurodegenerative condition characterized by both motor and nonmotor symptoms. The most common treatment is dopamine replacement therapy, but more effective interventions are urgently needed. Potential novel therapeutic interventions focus on nicotine, the nicotinic cholinergic system, butyrate, and fatty acid receptors.

NEUROTOXICITY RESEARCH (2021)

Add to Collection

Article Nutrition & Dietetics

Placental Antioxidant Defenses and Autophagy-Related Genes in Maternal Obesity and Gestational Diabetes Mellitus

Cecilia Diceglie et al.

Summary: Maternal obesity and gestational diabetes mellitus (GDM) are increasing globally, posing risks for both mothers and children. This study investigated the expression of antioxidant and autophagy-related genes in obese pregnant women with and without GDM. Results showed alterations in gene expression, suggesting a potential role of placental autophagy in metabolic pregnancy disorders and diabetes treatment.

NUTRIENTS (2021)

Add to Collection

Article Clinical Neurology

Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit

Alessandro Tozzi et al.

Summary: The study identified that alpha-synuclein disrupts dopamine system and striatal synaptic plasticity in early stages of Parkinson's disease. Subchronic treatment with L-DOPA was able to rescue alpha-synuclein-induced alterations, showing the critical role of dysfunctional dopamine system in disease progression.

BRAIN (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Autophagy in major human diseases

Daniel J. Klionsky et al.

Summary: Autophagy is crucial for maintaining cellular and organismal homeostasis, and dysfunction in autophagy is implicated in the pathogenesis of major human disorders across various organ systems.

EMBO JOURNAL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease

Claudio Giuliano et al.

Summary: The study found that CBD has the potential therapeutic effects on Parkinson's disease, reducing neurodegeneration, dampening neuroinflammatory responses, and improving motor performance. Specifically, CBD has a preferential action on astrocytes and activates the transient receptor potential vanilloid 1, enhancing the endogenous neuroprotective response.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Neuronal autophagy and mitophagy in Parkinson's disease

Britney N. Lizama et al.

Summary: Autophagy is crucial for cells to remove damaged components and is increasingly studied for its role in various diseases. Research on autophagy and mitochondrial quality control is expanding, particularly in relation to conditions like cancer, immune diseases, and neurodegenerative diseases.

MOLECULAR ASPECTS OF MEDICINE (2021)

Add to Collection

Article Pharmacology & Pharmacy

Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling

Jia-Xin Li et al.

Summary: The study found that the active compound Tricin in the Weijing formula targets PRKCA to suppress cancer cell growth in treating NSCLC. In vitro experiments showed vital effects of Tricin on Lewis lung carcinoma cells. The study concluded that Weijing formula and Tricin are promising alternative treatments for NSCLC patients.

PHARMACOLOGICAL RESEARCH (2021)

Add to Collection

Article Plant Sciences

Natural flavone tricin exerted anti-inflammatory activity in macrophage via NF-κB pathway and ameliorated acute colitis in mice

Xiao-Xiao Li et al.

Summary: This study demonstrated that tricin reduces inflammation in macrophages by modulating the NF-κB pathway, reverses colon length reduction, lowers myeloperoxidase activities and DAI scores, and restores myeloid-derived suppressive cell levels in acute colitis mice. Additionally, tricin treatment alleviates the effects of DSS on gut microbiota composition.

PHYTOMEDICINE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The STING1 network regulates autophagy and cell death

Ruoxi Zhang et al.

Summary: STING1 plays a crucial role in infection, inflammation, and immunity by activating transcription factors, as well as regulating autophagy and various cell death modalities. Understanding the signaling pathways of STING1 may provide insights into new therapeutic targets.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Article Clinical Neurology

Prodromal neuroinvasion of pathological α-synuclein in brainstem reticular nuclei and white matter lesions in a model of α-synucleinopathy

Nelson Ferreira et al.

Summary: The study in a rodent model demonstrates that peripheral inoculation of alpha-synuclein can lead to pathological progression in the central nervous system, with initial lesions appearing in motor neurons and the spinal cord. These findings provide valuable insights into the propagation of alpha-synuclein pathology in the nervous system.

BRAIN COMMUNICATIONS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Schisandra chinensis protects against dopaminergic neuronal oxidative stress, neuroinflammation and apoptosis via the BDNF/Nrf2/NF-κB pathway in 6-OHDA-induced Parkinson's disease mice

Tingxu Yan et al.

Summary: The study revealed that Schisandra chinensis protects against dopaminergic neurodegeneration in 6-OHDA-induced Parkinson's disease mice by modulating the BDNF/Nrf2/NF-kappa B signaling pathway to suppress oxidative stress, neuroinflammation, and apoptosis.

FOOD & FUNCTION (2021)

Add to Collection

Article Chemistry, Medicinal

Neuroprotective effects of kukoamine A on 6-OHDA-induced Parkinson's model through apoptosis and iron accumulation inhibition

Xin Li et al.

Summary: KuA demonstrates neuroprotective effects in PD models by inhibiting apoptosis, maintaining iron homeostasis, and reducing α-synuclein expression. These findings suggest that KuA may be a potential treatment for Parkinson's disease.

CHINESE HERBAL MEDICINES (2021)

Add to Collection

Article Cell Biology

Ischemia-induced upregulation of autophagy preludes dysfunctional lysosomal storage and associated synaptic impairments in neurons

Xia Zhang et al.

Summary: This study revealed that in a model of oxygen-glucose deprivation, autophagy dysfunction leads to impairment of synaptic structures. Dysfunctional lysosomal storage during ischemic stress affects the balance of autophagy-lysosomal machinery crucial for maintaining neuronal synaptic function.

AUTOPHAGY (2021)

Add to Collection

Article Cell Biology

Upregulation of ATG7 attenuates motor neuron dysfunction associated with depletion of TARDBP/TDP-43

Aneesh Donde et al.

AUTOPHAGY (2020)

Add to Collection

Article Environmental Sciences

Protective effects of trehalose against Mn-induced α-synuclein oligomerization in mice: Involvement of oxidative stress and autophagy

Meng-Jiao Jing et al.

ENVIRONMENTAL TOXICOLOGY (2020)

Add to Collection

Review Clinical Neurology

Parkinson disease

R. Balestrino et al.

EUROPEAN JOURNAL OF NEUROLOGY (2020)

Add to Collection

Review Chemistry, Multidisciplinary

Targeting the cholinergic system in Parkinson's disease

Changliang Liu

ACTA PHARMACOLOGICA SINICA (2020)

Add to Collection

Article Clinical Neurology

alpha-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model

Tomoyuki Taguchi et al.

BRAIN (2020)

Add to Collection

Review Medicine, Research & Experimental

The benefits and mechanisms of exercise training for Parkinson's disease

Ya-Shuo Feng et al.

LIFE SCIENCES (2020)

Add to Collection

Article Pharmacology & Pharmacy

Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson's disease: a multiple treatment comparison meta-analysis

Caroline D. Binde et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2020)

Add to Collection

Review Cell Biology

Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications

Marta Pajares et al.

CELLS (2020)

Add to Collection

Article Plant Sciences

Protective effect of hydroxysafflor yellow A on dopaminergic neurons against 6-hydroxydopamine, activating anti-apoptotic and anti-neuroinflammatory pathways

Xiaomei Yang et al.

PHARMACEUTICAL BIOLOGY (2020)

Add to Collection

Article Neurosciences

Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson's disease model

Jinyuan Yan et al.

BMC NEUROSCIENCE (2019)

Add to Collection

Article Nutrition & Dietetics

Effect of Vasicinone against Paraquat-Induced MAPK/p53-Mediated Apoptosis via the IGF-1R/PI3K/AKT Pathway in a Parkinson's Disease-Associated SH-SY5Y Cell Model

Da-Tong Ju et al.

NUTRIENTS (2019)

Add to Collection

Review Medicine, General & Internal

Parkinson's Disease: Clinical Review and Update

Veronica Cabreira et al.

ACTA MEDICA PORTUGUESA (2019)

Add to Collection

Article Chemistry, Medicinal

Schisandrin A ameliorates MPTP-induced Parkinson's disease in a mouse model via regulation of brain autophagy

Yinghao Zhi et al.

ARCHIVES OF PHARMACAL RESEARCH (2019)

Add to Collection

Article Geriatrics & Gerontology

Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson's Disease

Li-Yuan Wang et al.

FRONTIERS IN AGING NEUROSCIENCE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Synthesis, characterization, antioxidant power and acute toxicity of some new azo-benzamide and azo-imidazolone derivatives with in vivo and in vitro antimicrobial evaluation

Mohammed Kareem Samad et al.

BIOORGANIC CHEMISTRY (2019)

Add to Collection

Article Pharmacology & Pharmacy

Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease

Yu Zhang et al.

PHARMACOLOGICAL RESEARCH (2019)

Add to Collection

Review Immunology

The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections

Parvaneh Mehrbod et al.

VIRULENCE (2019)

Add to Collection

Article Immunology

Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model

Neha Sharma et al.

INFLAMMOPHARMACOLOGY (2018)

Add to Collection

Article Cell Biology

Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models

Jia Liu et al.

AUTOPHAGY (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Prevention of progression in Parkinson's disease

Jan Aaseth et al.

BIOMETALS (2018)

Add to Collection

Article Medicine, General & Internal

Rapamycin treatment for amyotrophic lateral sclerosis Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial)

Jessica Mandrioli et al.

MEDICINE (2018)

Add to Collection

Review Neurosciences

Association Between Autophagy and Neurodegenerative Diseases

Nobuhiro Fujikake et al.

FRONTIERS IN NEUROSCIENCE (2018)

Add to Collection

Review Biochemistry & Molecular Biology

α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies

Yvette C. Wong et al.

NATURE MEDICINE (2017)

Add to Collection

Article Pharmacology & Pharmacy

Hederagenin and α-hederin promote degradation of proteins in neurodegenerative diseases and improve motor deficits in MPTP-mice

An-Guo Wu et al.

PHARMACOLOGICAL RESEARCH (2017)

Add to Collection

Review Biochemistry & Molecular Biology

Autophagy in stem and progenitor cells

Carlo Rodolfo et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2016)

Add to Collection

Review Cell Biology

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky et al.

AUTOPHAGY (2016)

Add to Collection

Review Public, Environmental & Occupational Health

The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis

Lauren Hirsch et al.

NEUROEPIDEMIOLOGY (2016)

Add to Collection

Article Clinical Neurology

Levodopa therapy for Parkinson disease A look backward and forward

Peter A. LeWitt et al.

NEUROLOGY (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Onjisaponin B Derived from Radix Polygalae Enhances Autophagy and Accelerates the Degradation of Mutant α-Synuclein and Huntingtin in PC-12 Cells

An-Guo Wu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)

Add to Collection

Review Neurosciences

The many faces of alpha-synuclein: from structure and toxicity to therapeutic target

Hilal A. Lashuel et al.

NATURE REVIEWS NEUROSCIENCE (2013)

Add to Collection

Article Biochemistry & Molecular Biology

Celastrol protects human neuroblastoma SH-SY5Y cells from rotenone-induced injury through induction of autophagy

Yong-Ning Deng et al.

NEUROCHEMISTRY INTERNATIONAL (2013)

Add to Collection

Article Neurosciences

Genetic analysis of the ATG7 gene promoter in sporadic Parkinson's disease

Dongfeng Chen et al.

NEUROSCIENCE LETTERS (2013)

Add to Collection

Article Cell Biology

Isorhynchophylline, a natural alkaloid, promotes the degradation of alpha-synuclein in neuronal cells via inducing autophagy

Jia-Hong Lu et al.

AUTOPHAGY (2012)

Add to Collection

Review Clinical Neurology

Therapies in Parkinson's disease

Joseph Jankovic et al.

CURRENT OPINION IN NEUROLOGY (2012)

Add to Collection

Article Medicine, Research & Experimental

The Role of Autophagy in Parkinson's Disease

Melinda A. Lynch-Day et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)

Add to Collection

Article Cell Biology

AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

Joungmok Kim et al.

NATURE CELL BIOLOGY (2011)

Add to Collection

Review Oncology

Autophagy: cellular and molecular mechanisms

Danielle Glick et al.

JOURNAL OF PATHOLOGY (2010)

Add to Collection

Article Multidisciplinary Sciences

Discovery of Atg5/Atg7-independent alternative macroautophagy

Yuya Nishida et al.

NATURE (2009)

Add to Collection

Article Cell Biology

Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3

Shunsuke Kimura et al.

AUTOPHAGY (2007)

Add to Collection

Article Cell Biology

Autophagy and neurodegeneration

Masaaki Komatsu et al.

AUTOPHAGY (2006)

Add to Collection

Review Clinical Neurology

Epidemiology of Parkinson's disease

Lonneke M. L. de Lau et al.

LANCET NEUROLOGY (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.